|Articles|May 1, 2010
- BioPharm International-05-01-2010
- Volume 23
- Issue 5
BioPharm International, May 2010 Issue (PDF)
Pfizer’s Qbd Approach to Achieving Process Understanding
Advertisement
Articles in this issue
almost 16 years ago
Healthcare Reform Expands Coverage, Promotes Innovationalmost 16 years ago
Pandemic Response: Progress and Challengesalmost 16 years ago
Managing CMOs with Complementary Capabilitiesalmost 16 years ago
Are You Ready for a Post-Reform World?almost 16 years ago
Building Partnerships Between Academia and Biosciences Companiesalmost 16 years ago
Applying Computational Fluid Dynamics Technology in Bioprocesses-Part 2Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
